MedTrace Logo

Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants

NCT01890850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2015-07-22

No results posted yet for this study

Summary

This study aims to estimate the risk factors associated with pertussis/whopping cough infection among infants less than one year of age in a United States (U.S.) commercially insured population. The study will utilize a large research data base associated with a geographically diverse U.S. health plan not limited by one geographic area or disease outbreak to evaluate pertussis in infants between 2005 and 2010. Healthcare costs and utilization among infants with a reported diagnosis of pertussis/whooping cough stratified by the number of DTaP vaccinations received prior to infection will also be reported.

Conditions

  • Diphtheria
  • Acellular Pertussis
  • Tetanus

Interventions

OTHER

Retrospective database study using administrative claims data

Data collection from OptumInsight proprietary research database which contains enrollment and claims data for individuals enrolled in commercial health plans.

Sponsors & Collaborators

  • Optum, Carolyn Martin and Ami Buikema

    collaborator UNKNOWN

  • GlaxoSmithKline

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-11-30
Completion
2013-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01890850 on ClinicalTrials.gov